Alastair Kent Director, Genetic Alliance UK Alastair Kent OBE is the Director of Genetic Alliance UK – the national charity of over 150 patient organisations, supporting all those affected by genetic conditions. Genetic Alliance UK’s mission is to promote the development of the scientific understanding of genetics and the part that genetic factors play in [...]
Ryan Hohman Managing Director, Policy & Public Affairs, Friends of Cancer Research Ryan Hohman, JD, serves as Managing Director, Policy & Public Affairs at Friends of Cancer Research (Friends), a think tank and advocacy organization based in Washington, D.C. Friends is our country’s leading voice in advocating for policies and proposing and promoting real solutions [...]
Adam Healthfield Director of Science Policy for Europe, Pfizer, UK Adam is Pfizer’s Director of Science Policy for Europe and works closely with the company’s R&D organisation to support European and global projects on orphan drugs and rare diseases, R&D productivity, collaborative research, stem cell science and personalised medicine. Adam has been a member of [...]
Joel Haspel Director Strategy & Business Development EMEA, Oracle Health Sciences Joel leads the overall healthcare strategy and business development in EMEA, working across the Oracle Health Sciences Global Business Unit strategy, alliance, sales, consulting and solution consulting teams as well as the extended technology, applications and Industry Business Unit groups. Leveraging his 25 years [...]
Jeremy Haigh European Chief Operating Officer, Amgen Jeremy Haigh is responsible for Amgen’s Research & Development sites across Europe, the Middle East and Africa (EMEA), and for Global Development staff located in the region. He is a director of Amgen Limited, BioVex Limited, and the recently acquired Amgen Research (Munich) GmbH, a member of the [...]
Michel Goldman Executive Director, IMI Michel Goldman is the chief executive responsible for the management of IMI in accordance with the decisions of the Governing Board. He is supported by the staff of the Executive Office. As the Executive Director of IMI, he builds and promotes networks of innovation, in close collaboration with all stakeholders [...]
Sarah Garner Associate Director, Research and Development, National Institutes of Clinical Excellence Dr Sarah Garner PhD, BPharm is a pharmacist specialising in Health Technology Assessment (HTA). Sarah is the Associate Director for R&D at the UK’s National Institute for Health and Clinical Excellence (NICE) and is responsible for the planning and delivery of NICE’s R&D [...]
George Freeman Parliamentary Under Secretary of State for Life Sciences, UK Government George was elected to Parliament in May 2010 after a 15 year career in and around the Cambridge cluster supporting high growth businesses. George won the 2010 election for the new constituency of Mid Norfolk, with a majority of 14,000, after an innovative [...]
Pat Furlong Founding President and CEO, Parent Project Muscular Dystrophy Pat Furlong is the Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest nonprofit organization in the United States solely focused on Duchenne muscular dystrophy (Duchenne). Its mission is to improve the treatment, quality of life, and long-term outlook for all individuals [...]
Gary Finnegan Editorial Consultant, Moderator Gary Finnegan is an award-winning journalist, editor and author, with a particular interest in health, research and innovation policy. He has written and edited a range of magazines, newspapers and websites, including EurActiv, where he was science and health section editor. Gary has also written extensively for the pharmaceutical, vaccine [...]